Trials / Unknown
UnknownNCT05159817
Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma
Monocentre, Observational Clinical Study Evaluating the Efficacy and Safety of a Novel Interposition Supraciliary Implant in Glaucoma Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Ciliatech · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to prolong observational follow-up up to 36 months of patients already implanted with a novel interposition supraciliary implant.
Detailed description
19 patients with primary open angle glaucoma (POAG) refractory to topical medical therapy were operated in late 2020 and a novel interposition supraciliary device implanted. These patients reached 6 months follow-up and the original study had to be interrupted. This observational study prolonges follow-up to 36 months
Conditions
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2024-02-28
- Completion
- 2024-12-31
- First posted
- 2021-12-16
- Last updated
- 2023-02-13
Locations
1 site across 1 country: Armenia
Source: ClinicalTrials.gov record NCT05159817. Inclusion in this directory is not an endorsement.